Edges in Network
| Network | GSE5851_top500tf - GSE5851 - SiGN-BN HC+Bootstrap |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | HMG20B |
| Upstream (Parents) |
|---|
| (<<) TFAP2C → HMG20B |
| (<<) TRIM29 → HMG20B |
| (<<) ZNF135 → HMG20B |
| (<<) TFAP2A → HMG20B |
| (<<) RFXAP → HMG20B |
| (<<) ZNF215 → HMG20B |
| (<<) MYBL2 → HMG20B |
| (<<) FOSL1 → HMG20B |
| (<<) ZGPAT → HMG20B |
| (<<) PTTG1 → HMG20B |
| (<<) ELK4 → HMG20B |
| (<<) PPBPL2 → HMG20B |
| Downstream (Children) |
|---|
| HMG20B → NEUROD1 (>>) |
| HMG20B → TLX1 (>>) |
| HMG20B → TADA2A (>>) |
| HMG20B → POU3F4 (>>) |
| HMG20B → BLZF1 (>>) |
| HMG20B → ZNF639 (>>) |
| HMG20B → FUBP1 (>>) |
| HMG20B → HES1 (>>) |
| HMG20B → HSF1 (>>) |
| HMG20B → TBX21 (>>) |
| HMG20B → HOXC4 (>>) |
| HMG20B → ZNF83 (>>) |
